drugset / Trial / NCT05683821

BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study

NCT05683821

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to see if offering adult primary care patients who smoke combustible cigarettes more frequent outreach, more choices about how they receive that outreach, and more smoking treatment options will increase the use of smoking treatments and help more people quit smoking, when compared against a standard outreach approach. Only patients at participating adult primary care clinics will be eligible for the study. Five clinic sites will be randomized to an enhanced outreach approach, while another 5 will be randomly assigned to standard smoking treatment outreach. Eligible patients at these clinics will be in this study for up to 18 months.

Timeline

Start
2023-07-24
Primary completion
2025-05-07
Completion
2025-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg
Subject Nicotine Unknown 4 mg
Subject Nicotine Unknown 7 mg
Subject Nicotine Unknown 14 mg
Subject Nicotine Unknown 21 mg

Indications

No indication recorded.